Zelenskyy Says Starshield Restrictions Threaten Ukraine’s Energy Defenses Ahead of WinterNovember 15, 2026
Olivia Thomas on November 15, 2026 6:02 pm Exploration results look promising, but permitting will be the key risk. Reply
Elijah Johnson on November 15, 2026 6:03 pm If AISC keeps dropping, this becomes investable for me. Reply
Olivia Johnson on November 15, 2026 6:03 pm I like the balance sheet here—less leverage than peers. Reply
Mary Thomas on November 15, 2026 6:03 pm Nice to see insider buying—usually a good signal in this space. Reply
James Johnson on November 15, 2026 6:04 pm Silver leverage is strong here; beta cuts both ways though. Reply
Amelia K. Rodriguez on November 15, 2026 6:04 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Michael Smith on November 15, 2026 6:05 pm Exploration results look promising, but permitting will be the key risk. Reply
Liam Martin on November 15, 2026 6:06 pm Silver leverage is strong here; beta cuts both ways though. Reply
Elijah Taylor on November 15, 2026 6:06 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Lucas S. Jones on November 15, 2026 6:08 pm Silver leverage is strong here; beta cuts both ways though. Reply
Linda Thompson on November 15, 2026 6:08 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Oliver Rodriguez on November 15, 2026 6:12 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Mary White on November 15, 2026 6:12 pm Nice to see insider buying—usually a good signal in this space. Reply
Elizabeth Miller on November 15, 2026 6:12 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
Lucas Johnson on November 15, 2026 6:13 pm I like the balance sheet here—less leverage than peers. Reply
William Smith on November 15, 2026 6:13 pm Silver leverage is strong here; beta cuts both ways though. Reply
Jennifer Thompson on November 15, 2026 6:14 pm Production mix shifting toward Videos might help margins if metals stay firm. Reply
Olivia K. Martinez on November 15, 2026 6:15 pm Interesting update on Dr. Craig Koniver – The Godfather of Peptides | SRS #330. Curious how the grades will trend next quarter. Reply
34 Comments
Exploration results look promising, but permitting will be the key risk.
If AISC keeps dropping, this becomes investable for me.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Interesting update on Dr. Craig Koniver – The Godfather of Peptides | SRS #330. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.